NF1 and neoplasm: The NF1 mutation observed in the BCX1 tumor increases growth factor Ras signaling (44), suggesting that receptor tyrosine kinase (RTK) signaling may represent an early escape pathway in the tamoxifen-resistant sublines BCX1TamR1 and BCX1TamR2.